The HTT CAG-Expansion Mutation Determines Age at Death but Not Disease Duration in Huntington Disease

Area of Science:

• Genetics
• Neurodegenerative Diseases
• Molecular Biology

Background:

• Huntington disease (HD) is a fatal neurodegenerative disorder caused by an expanded CAG repeat in the HTT gene.
• The expanded CAG repeat length is known to influence the age of motor symptom onset in HD patients.
• HD is characterized by early mortality, prompting investigation into the repeat's influence on lifespan and disease progression.

Purpose of the Study:

• To determine if the expanded CAG repeat length in the HTT gene influences Huntington disease (HD) age at death and disease duration.
• To investigate the dominant influence of the expanded CAG repeat on mortality and clinical disease duration.
• To explore potential mechanisms underlying HD pathogenesis and their implications for therapeutic development.

Main Methods:

• Analysis of expanded CAG repeat length in the HTT gene.
• Correlation of CAG repeat length with age at death in HD patients.
• Assessment of disease duration in relation to CAG repeat length and genetic modifiers.

Main Results:

• Age at death in Huntington disease (HD) is significantly determined by the expanded HTT CAG repeat length, similar to clinical onset.
• The normal CAG allele does not contribute to the age at death.
• Surprisingly, disease duration in HD is independent of the expanded CAG repeat's length and unaffected by known genetic modifiers of motor onset.

Conclusions:

• These findings suggest that while CAG repeat length drives HD onset and mortality, disease duration may be governed by CAG-independent processes after motor onset.
• Alternatively, distinct cellular targets with different time courses, influenced by CAG length, may lead to motor onset and death independently.
• Understanding these distinct CAG-dependent and independent pathways is crucial for designing effective Huntington disease therapeutics.